Citadel Advisors’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
617,085
+14,568
| +2% | +$49.5K | ﹤0.01% | 2641 |
|
|
2025
Q1 | $2.42M | Buy |
602,517
+401,377
| +200% | +$1.61M | ﹤0.01% | 2409 |
|
|
2024
Q4 | $1.31M | Sell |
201,140
-69,432
| -26% | -$451K | ﹤0.01% | 3029 |
|
|
2024
Q3 | $1.5M | Buy |
270,572
+213,444
| +374% | +$1.18M | ﹤0.01% | 2745 |
|
|
2024
Q2 | $319K | Buy |
+57,128
| New | +$319K | ﹤0.01% | 4251 |
|
|
2023
Q4 | – | Sell |
-404
| Closed | -$2.23K | – | 5987 |
|
|
2023
Q3 | $2.23K | Sell |
404
-755
| -65% | -$4.17K | ﹤0.01% | 5627 |
|
|
2023
Q2 | $9.9K | Sell |
1,159
-391,733
| -100% | -$3.35M | ﹤0.01% | 5381 |
|
|
2023
Q1 | $3.61M | Buy |
392,892
+343,750
| +700% | +$3.16M | ﹤0.01% | 2064 |
|
|
2022
Q4 | $502K | Buy |
+49,142
| New | +$502K | ﹤0.01% | 3842 |
|
|
2022
Q3 | – | Sell |
-264,928
| Closed | -$2.84M | – | 5994 |
|
|
2022
Q2 | $2.84M | Buy |
264,928
+239,579
| +945% | +$2.57M | ﹤0.01% | 2399 |
|
|
2022
Q1 | $273K | Sell |
25,349
-67,020
| -73% | -$722K | ﹤0.01% | 5015 |
|
|
2021
Q4 | $1.51M | Buy |
92,369
+77,051
| +503% | +$1.26M | ﹤0.01% | 3340 |
|
|
2021
Q3 | $328K | Buy |
+15,318
| New | +$328K | ﹤0.01% | 4948 |
|